All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each
Preview: Takeda Pharmaceutical's Earnings
October 30, 2024
Via Benzinga
HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
November 21, 2024
Via GlobeNewswire
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
November 12, 2024
Via Benzinga
Topics
Climate Change
Exposures
Climate
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire
Via PressReach
Exposures
Product Safety
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |